Evaluation of the Action of MOBIDERM® on Periarticular Edema After Total Knee Prosthesis - Randomized Controlled
MOBŒDEM
1 other identifier
interventional
44
1 country
1
Brief Summary
We hypothesize that the use of MOBIDERM® after total knee prosthesis allows a greater and faster resorption of periarticular edema:
- improvement of knee flexion;
- faster functional gain;
- faster decrease in postoperative pain by decreasing tissue tension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2019
CompletedFirst Posted
Study publicly available on registry
March 7, 2019
CompletedStudy Start
First participant enrolled
July 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 3, 2022
CompletedFebruary 11, 2022
February 1, 2022
2.4 years
March 6, 2019
February 10, 2022
Conditions
Outcome Measures
Primary Outcomes (6)
Knee volume
unit: mm3
Day -1
Knee volume
unit: mm3
Day 0
Knee volume
unit: mm3
Day 1
Knee volume
unit: mm3
Day 5
Knee volume
unit: mm3
Day 15
Knee volume
unit: mm3
Month 1
Secondary Outcomes (25)
visual analog pain scale visual analog pain scale
Day 1
visual analog pain scale visual analog pain scale
Day 3
visual analog pain scale visual analog pain scale
Day 5
visual analog pain scale visual analog pain scale
Day 15
visual analog pain scale visual analog pain scale
Month 1
- +20 more secondary outcomes
Study Arms (2)
MOBIDERM group
EXPERIMENTALControl group
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- Patient requiring a first total knee prosthesis (scheduled between Tuesday and Friday).
- Patient that has given his/her free and informed consent and signed the consent form.
- The patient must be a member or beneficiary of a health insurance plan
- The patient is at least 18 years old (≥) and under 90 years old (\<).
You may not qualify if:
- The subject refuses to sign the consent
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
- The patient is pregnant or breastfeeding
- The patient is allergic to latex bandages.
- The subject has contralateral amputation, pressure ulcers, severe Obstructive Arteriopathy of Lower Limbs, lymphoedema or thromboembolic event of the lower limb (ipsilateral and / or contralateral / superficial or deep or detected by postoperative Doppler).
- The subject has chronic or active wounds or any cause that hinders normal rehabilitation or the application of a bandage.
- patient with a stroke / Disabling Neurological Pathology, Chronic Immunological Pathology / Systemic Disease.
- patient with Hepatic insufficiency.
- patient with Venous insufficiency (stages 3 and 4).
- The patient is on dialysis.
- The subject has cognitive or behavioral disorders (Parkinson's disease, cerebellar syndrome, opposition, agitation, dementia).
- The subject has a history of knee surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nîmes University Hospital
Nîmes, 30029, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2019
First Posted
March 7, 2019
Study Start
July 26, 2019
Primary Completion
December 14, 2021
Study Completion
February 3, 2022
Last Updated
February 11, 2022
Record last verified: 2022-02